EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Do the redefined EUCAST susceptibility categories warrant adjustment of paediatric antibiotic dosages? Pragmatic physiologically based pharmacokinetic modelling of four commonly used agents

Marika A de Hoop-Sommen iD, Jolien J M Freriksen, Joyce E M van der Heijden, Jens Jacobs, Yvette Oosterlaan, Chantal M Staring, Shannon L van der Zeeuw, Tjitske M van der Zanden, Jan-Tom van der Bruggen, Marjolijn S W Quaak, Clementien Vermont iD, Tom F W Wolfs und 3 weitere

Journal of Antimicrobial Chemotherapy · 19.01.2026 · 81 (2)

DOI: 10.1093/jac/dkaf463 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 29.01.2026. Verfasst von Marika A de Hoop-Sommen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, Bill & Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objective With the redefinition of the EUCAST ‘I’ susceptibility category, from ‘intermediate’ to ‘susceptible, increased exposure’, the focus is now to use higher doses to treat infections of this category. These higher dosages in adults provided by EUCAST are fixed, yet it is uncertain whether a similar increase should apply to paediatric doses. We aimed to compare antibiotic exposure in adults and children, using pragmatic physiologically based pharmacokinetic (PBPK) modelling and simulation to evaluate the need for dose increases in children for the ‘I’ susceptibility category micro-organisms.

Methods

For amoxicillin, ceftazidime, cefuroxime and ciprofloxacin, we used existing PBPK models and verified them with published adult and paediatric pharmacokinetic data. Then, the adult EUCAST category ‘I’ doses and a wide paediatric dosage range was simulated. We compared AUC values as a surrogate for antibiotic exposure. In addition, simulations were performed to assess the PTA of the adult and paediatric doses for specific drug–micro-organism combinations.

Results

Model verification proved successful for all antibiotics. Simulations showed that antibiotic plasma exposure increases with decreasing age using current paediatric doses. Simulating doses for neonates and infants resulted in substantially higher AUCs compared with adults receiving the EUCAST ‘I’ dose. Simulations showed that PTA is highly variable with age and can be poor in case of less susceptible micro-organisms.

Conclusions

In contrast to adults, there is no need to increase the currently recommended paediatric dosages for the tested antibiotics. At the same time, further simulations showed that the PTA varies by drug-micro-organism combination and age, providing a potential opportunity to tailor doses to individual patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsHumansChildInfantChild, PreschoolAdultMicrobial Sensitivity TestsInfant, NewbornCefuroximeComputer SimulationCiprofloxacinCeftazidimeAmoxicillinAdolescentThird Generation CephalosporinsSecond Generation CephalosporinsModels, Biological

Substanzen

Anti-Bacterial AgentsCefuroximeCiprofloxacinCeftazidimeAmoxicillinThird Generation CephalosporinsSecond Generation Cephalosporins

Autor:innen und Institutionen

  • Department of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Department of Hospital Pharmacy, Erasmus MC, Rotterdam, The Netherlands.
  • Department of Paediatric and Neonatal Intensive Care, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Dutch Knowledge Centre Pharmacotherapy for Children, The Hague, The Netherlands.
  • Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Department of Paediatrics, Dijklander Ziekenhuis, Hoorn, The Netherlands.

ORCID-Profile: Marika A de Hoop-Sommen, Clementien Vermont, Roger J M Brüggemann

Förderung

  • Gates Foundation
  • Bill & Melinda Gates Foundation

Zitieren

APA

de Hoop-Sommen, M. A., Freriksen, J. J. M., van der Heijden, J. E. M., Jacobs, J., Oosterlaan, Y., Staring, C. M., van der Zeeuw, S. L., van der Zanden, T. M., van der Bruggen, J. T., Quaak, M. S. W., Vermont, C., Wolfs, T. F. W., Brüggemann, R. J. M., Greupink, R., & de Wildt, S. N. (2026). Do the redefined EUCAST susceptibility categories warrant adjustment of paediatric antibiotic dosages? Pragmatic physiologically based pharmacokinetic modelling of four commonly used agents. Journal of Antimicrobial Chemotherapy, 81(2). https://doi.org/10.1093/jac/dkaf463

Vancouver

de Hoop-Sommen MA, Freriksen JJM, van der Heijden JEM, Jacobs J, Oosterlaan Y, Staring CM, et al. Do the redefined EUCAST susceptibility categories warrant adjustment of paediatric antibiotic dosages? Pragmatic physiologically based pharmacokinetic modelling of four commonly used agents. Journal of Antimicrobial Chemotherapy. 2026;81(2). doi:10.1093/jac/dkaf463

BibTeX
@article{deHoopSommen2026,
  author = {de Hoop-Sommen, Marika A and Freriksen, Jolien J M and van der Heijden, Joyce E M and Jacobs, Jens and Oosterlaan, Yvette and Staring, Chantal M and van der Zeeuw, Shannon L and van der Zanden, Tjitske M and van der Bruggen, Jan-Tom and Quaak, Marjolijn S W and Vermont, Clementien and Wolfs, Tom F W and Brüggemann, Roger J M and Greupink, Rick and de Wildt, Saskia N},
  title = {Do the redefined EUCAST susceptibility categories warrant adjustment of paediatric antibiotic dosages? Pragmatic physiologically based pharmacokinetic modelling of four commonly used agents},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  volume = {81},
  number = {2},
  doi = {10.1093/jac/dkaf463}
}
Kostenlos starten →